Skip to content
Food Beverages, Medical Health Aged Care

It’s Whole Grain Week

Grains and Legumes Nutrition Council 2 mins read

The Grains & Legumes Nutrition Council (GLNC) is excited to celebrate Whole Grain Week from the 13th to the 19th of November, aligning with the global celebration of International Whole Grain Day on the 15th of November. This year's national and international campaign is focused on encouraging the whole family to eat whole grains.

 

In Australia, whole grain consumption is below the recommended daily target intake for all age groups. Whole grains are essential for a balanced diet, promoting healthy growth and reducing the risk of chronic diseases by 20-30 per cent. According to recent findings from The Lancet, low whole grain intake is a leading dietary risk factor for mortality. The GLNC General Manager, Kathy La Macchia, emphasises, “Now, more than ever, it is crucial to encourage the whole family to embrace whole grains.”

 

This year’s campaign highlights three key areas:

  • The benefits of whole grains for the whole family.
  • How to incorporate whole grains into the whole day.
  • Why Australians need whole grains for a whole tomorrow.

To amplify the message and make whole grains more accessible, GLNC is partnering with leading researchers, nutritionists, dietitians, government groups, grain growers and food manufacturers, including The Arnott’s Group, George Weston Food, Cereal Partners Worldwide, Sanitarium Health Food Company, and Bakers Delight. Together, they have created a free eBook containing over 40 delicious, whole grain recipes designed for families.

 

GLNC is raising awareness of the week through various other mediums, including articles, podcasts, video content and collaborations with health-qualified influencers. To explore the importance of grains for a healthier future, the GLNC is working with an academic and Churchill Fellow who specialises in native grains.

 

For free resources, including the recipe eBook, podcast episodes and more, visit the Grains & Legumes Nutrition Council’s website.

 


Key Facts:

The Grains and Legumes Nutrition Council (GLNC) invites you to celebrate Whole Grain Week from the 13th to the 19th of November. 


About us:

The Grains and Legumes Nutrition Council (GLNC) is the independent authority on the nutrition and health benefits of grains and legumes. The GLNC is committed to providing accurate and evidence-based information as a not-for-profit and recognised health promotion charity.


Contact details:

Toni Gam

Marketing and Communications Manager

 

Grains and Legumes Nutrition Council

 

https://www.glnc.org.au/whole-grain-week

 

[email protected]

 

0428 957 559

Media

More from this category

  • Medical Health Aged Care
  • 08/12/2025
  • 10:11
BeOne Medicines Ltd.

Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies

Novel BCL2 inhibitor sonrotoclax monotherapy demonstrates deep and durable clinical responses in R/R MCL and R/R CLL Sonrotoclax in combination with BRUKINSA demonstrated rapid…

  • Contains:
  • Medical Health Aged Care
  • 08/12/2025
  • 09:40
Miltenyi Biomedicine

Miltenyi Biomedicine presents primary analysis of the pivotal DALY 2-EU trial for second-line relapsed/refractory large B-cell lymphoma at the 67th American Society of Hematology (ASH) Annual Meeting

DALY 2-EU results show zamtocabtagene autoleucel (zamto-cel) demonstrated clinically meaningful superiority over chemoimmunotherapy in patients with relapsed/refractory large B-cell lymphoma (r/r LBCL)1Zamto-cel was well-tolerated in the majority of patients. DALY 2-EU included a high-risk study population, characterized by older age and clinically high-risk disease featuresA 12-day manufacturing time resulted in a vein-to-vein time of 14-16 days, reducing the likelihood for bridging therapy.BERGISCH GLADBACH, Germany, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Miltenyi Biomedicine today announced results from the pivotal DALY 2-EU trial evaluating the efficacy and safety of zamtocabtagene autoleucel (zamto-cel) compared with standard chemoimmunotherapy (R-GemOx or Pola-BR) in patients with…

  • Medical Health Aged Care, Seniors Interest
  • 08/12/2025
  • 08:56
Monash University

Men and women may need different medications to avoid broken bones

A new international study, published in Osteoporosis International and led by Monash’s Centre for Medicine Use and Safety (CMUS), investigated the risks of a…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.